A+ chronicity has previously been associated with entorhinal tau at the cross-sectional level in sporadic AD, where tau burden increases were estimated to occur 5-10 years following A+ onset, but with considerable inter-individual heterogeneity in a cohort of mostly initially unimpaired, at-risk adults [35]. This evidence concerns the gene MAPT and Alzheimer disease.